Finance

Beta
Lists
NTLX:CVE
Neurothera Labs Inc
CA$0.18
0.00%
(0.00) 1D
Jun 3, 10:56:25 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NTLX...
Mkt. cap
15.28M
Avg. vol.
400.00
Volume
0.00
52-wk high
CA$0.26
52-wk low
CA$0.16
EPS
-CA$0.01
Beta
0.30
Shares outstanding
20.85M
Mkt. cap
15.28M
Avg. vol.
400.00
Volume
0.00
52-wk high
CA$0.26
52-wk low
CA$0.16
EPS
-CA$0.01
Beta
0.30
Shares outstanding
20.85M
News stories
From sources across the web
About Neurothera Labs Inc
CEO-
Employees-
Founded2021
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websiteneurothera.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2024
Dec 2024
Sep 2025
Dec 2025
Revenue
260.00K
206.00K
236.00K
159.00K
Cost of goods sold
91.00K
343.00K
70.00K
54.00K
Cost of revenue
91.00K
343.00K
70.00K
54.00K
Research and development expenses
-
1.71M
-
1.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
338.00K
305.00K
260.00K
777.00K
Operating expense
338.00K
2.01M
260.00K
2.58M
Total operating expenses
429.00K
2.36M
330.00K
2.63M
Operating income
-169.00K
-2.15M
-94.00K
-2.47M
Other non operating income
-
-
-
-1.41M
EBT including unusual items
-169.00K
-3.47M
-94.00K
-4.08M
EBT excluding unusual items
-169.00K
-2.13M
-94.00K
-3.96M
Income tax expense
-
5.00K
-
19.00K
Effective tax rate
-
-0.14%
-
-0.47%
Other operating expenses
-
-
-
-
Net income
-169.00K
-2.29M
-94.00K
-3.86M
Net profit margin
-65.00%
-1,112.14%
-39.83%
-2,427.04%
Earnings per share
-
-
-
-
Interest and investment income
-
22.00K
-
43.00K
Interest expense
-
-
-
-125.00K
Net interest expenses
-
22.00K
-
-82.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-77.33K
-2.06M
-46.00K
-2.42M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer